1-3 of 3
Michael W. Deininger
Close
Sort by
Journal Articles

Efficacy and safety of avapritinib in previously treated patients with advanced systemic mastocytosis

Clinical Trials & Observations
Andreas Reiter, Juliana Schwaab, Daniel J. DeAngelo, Jason Gotlib, Michael W. Deininger, Kristen M. Pettit, Iván Alvarez-Twose, Alessandro M. Vannucchi, Jens Panse, Uwe Platzbecker, Olivier Hermine, Ingunn Dybedal, Hui-Min Lin, Svetlana N. Rylova, Katrin Ehlert, Saša Dimitrijević, Deepti H. Radia
Journal: Blood Advances
Blood Adv (2022) 6 (21): 5750–5762.
https://doi.org/10.1182/bloodadvances.2022007539
Published: 2022
Includes: Supplemental data
Journal Articles

The transcriptome of CMML monocytes is highly inflammatory and reflects leukemia-specific and age-related alterations

Anca Franzini, Anthony D. Pomicter, Dongqing Yan, Jamshid S. Khorashad, Srinivas K. Tantravahi, Hein Than, Jonathan M. Ahmann, Thomas O’Hare, Michael W. Deininger
Journal: Blood Advances
Blood Adv (2019) 3 (20): 2949–2961.
https://doi.org/10.1182/bloodadvances.2019000585
Published: 2019
Includes: Supplemental data
Journal Articles

Leukemoid reaction in chronic myelomonocytic leukemia patients undergoing surgery: perioperative management recommendations

Clinical Trials & Observations
Ami B. Patel, Erin M. Pettijohn, Sameem M. Abedin, Evan Raps, Michael W. Deininger
Journal: Blood Advances
Blood Adv (2019) 3 (7): 952–955.
https://doi.org/10.1182/bloodadvances.2019032300
Published: 2019